NMS-812, a novel potent PERK inhibitor that also inhibits GCN2, exhibits strong antitumor activity as single agent and in combination in preclinical modelsClaudia Perrera,Maurizio Pulici,Patrizia Banfi,Nilla Avanzi,Davide Carenzi,Daniele Casero,Antonella Ciavolella,Laura Gianellini,Fabio Gasparri,Grazia Saturno,Barbara Valsasina,Elena Ardini,Alessia Montagnoli,Arturo P. Galvani,Antonella IsacchiCANCER RESEARCH（2023）引用 0|浏览29暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
